Clinical Trials
2 trialsNCT07120451 2025-08-13
Combination Therapy of Senaparib and Bevacizumab for First-line Maintenance Therapy in Newly Diagnosed Advanced Homologous Recombination Proficient Ovarian Cancer Based on Exosome Protein Marker
Fudan University
Phase 2 Not yet recruiting
NCT07059676 2025-07-11
LIBINI-1
Clinica Universidad de Navarra, Universidad de Navarra
Not yet recruiting